Is neuroprotection a viable treatment option for glaucoma? Drs. Robert Weinreb, Jay Katz, and Theodore Krupin explore the possibilities.
Author: Medscape
Are You Prescribing Unapproved Drugs?
Some drugs that are currently on the market have never been approved by the US Food and Drug Administration (FDA).
Is Healthcare a Right or a Privilege?
Dr. John Marshall asks: If health insurance is a choice that individuals can opt not to have, who pays for the care of the 40 million people in the United States who have no healthcare insurance?
Stop Hounding Patients to Give Up Their Privacy
Many people think that privacy of medical treatment should not apply to everyone. An ethics expert tells why privacy protects all of society.
FDA Commissioner: "Safety Science" Key to Drug Regulation
Dr. Margaret Hamburg talks with Dr. Eli Adashi about the complex role of the US Food and Drug Administration in approving new drugs while still ensuring their safety.
Dr. John Howard From CDC’s NIOSH Discusses the Consequences of the Gulf Oil Spill
John Howard, MD, MPH, JD, Director, NIOSH, talks to Eli Adashi, MD, about the efforts to protect health during and after the Gulf oil spill.
Laser-Assisted Cataract Surgery: Development and Application
Dr. James Salz discusses the emerging use of lasers to assist in performing cataract surgery.
Why Do Patients "Disrespect" Doctors?
When physicians make patients feel like it’s "business first, patient care second," they may lose their patients’ respect, says Dr. Gerald Chodak.
EHRs Create Startling New Moral Quandaries
As more physicians use EHRs, more ethical issues arise, including patient privacy issues. Also, is it unethical not to use computer technology?
Lowering Intraocular Pressure in Glaucoma: Medical Therapy vs Surgical Therapy
Drs. L. Jay Katz, Ronald Gross, and Brian Francis discuss the evolving medical and surgical approaches to lowering IOP in patients with glaucoma.
Do Physician Payments Bias Their Treatment Recommendations?
If a given diagnosis were covered by 1 lump sum, would physicians recommend less expensive treatments more often? Dr. Gerald Chodak examines the issue.
New Treatments for Diabetic Retinopathy: AAO 2010
In this video commentary, Dr. David Brown ponders the new paradigm of pharmacotherapy for diabetic retinopathy — and what this means for laser therapy.
A Simple Way to Avoid Malpractice Litigation
Dr. Jeffrey Lieberman discusses physician vulnerability to legal accusations and offers a simple means of reducing malpractice risk.
Glaucoma and Ocular Surface Disease: Differentiating Between Disease and Treatment Side Effects
Drs. Robert Fechtner and Clark Springs discuss how best to manage 2 challenging cases of patients with co-occurring glaucoma and ocular surface disease.
Retinal Disease Progression: Immediate Treatment vs Watchful Waiting
In this video commentary, Dr. David Brown offers advice regarding time to treatment of the different types of retinal disease entities.
Does SD-OCT Imaging Contribute to Better Outcomes in Cataract Surgery?
In this video commentary, Dr. David Brown shares tips for using SD-OCT imaging in the perioperative period of cataract surgery to boost surgical success and patient satisfaction.
Neglected Infections of Poverty – Toxocariasis
In this CDC Expert Commentary, LCDR Paul T. Cantey describes toxocariasis, a common, yet little known parasitic disease associated with pet ownership.
Separating Docs From Industry — A Witch Hunt?
Frank Veith, MD, believes that the initiative to separate physicians from industry is excessive and can lead to harm for patients. What do you think?
Safe Use of Drugs Requires Reports From Clinicians
The Safe Use Initiative is taking aim at adverse drug events and seeks input on safety issues encountered by frontline clinicians.
What Obama Didn’t Say — The Supportive Position
Robert Morrow, MD, stressed what Obama left out and is encouraged by the future implementation of many positive changes, particularly for primary care.